The John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency

Funding Agency:
Alpha-1 Foundation

This award is named after John W. Walsh, who dedicated his life’s work to finding a cure for Alpha-1 Antitrypsin Deficiency. Walsh and two others, all with Alpha-1 themselves, founded both the Alpha-1 Foundation and AlphaNet in 1995.

.Walsh has always referred to himself as an “impatient patient,” and this award, aimed specifically at translating research findings into medical practice, is intended to carry on his commitment to a cure.

Deadline: Feb. 28, 2020

Agency Website

Eligibility Requirements

Eligible candidates for this award must have a clinical or research doctorate (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.M.D., D.V.M., Sc.D., D.N.S., Pharm.D. or an equivalent doctoral degree).

At the time this award, the candidate must have a “full-time” appointment at the applicant institution. Candidates who have VA appointments may not consider part of the VA effort toward satisfying the “full-time” requirement at the applicant institution. Candidates with VA appointments should contact the staff person in the relevant Institute or Center prior to preparing an application to discuss their eligibility.



Amount Description

Amount of Grant: up to $225,000 ($75,000/year) over three (3) years to fund one (1) award.

Funding Type





Medical - Translational

External Deadline

February 28, 2020